Mosaic theory in biology describes how a single organism can contain cells with different genetic makeups, even though every cell descended from the same fertilized egg. This happens because DNA changes occur after conception, during the millions of cell divisions that build a body. The result is a patchwork: some cells carry the original genetic code, while others carry altered versions. This concept has far-reaching implications for human health, from skin conditions to cancer to brain development.
Origins of the Idea
The concept traces back to the German biologist August Weismann, who in his 1893 work “The Germ Plasm: A Theory of Heredity” proposed that cells could divide in two different ways. In what he called “ordinary” divisions, daughter cells received identical copies of their nuclear contents. In “embryogenic” divisions, daughter cells received unequal shares, with each cell retaining only the genetic material needed for its destined role. Weismann was working before anyone understood genes or DNA, but his core insight held: cells within the same body can end up with different genetic instructions.
Modern science has refined this dramatically. We now know that cell division normally produces identical copies, but errors during that copying process create genetic differences between cells. These errors, called post-zygotic mutations (because they happen after the fertilized egg, or zygote, forms), are the true engine of mosaicism.
How Mosaicism Happens
Every time a cell divides, it copies roughly 3 billion letters of DNA. Mistakes are inevitable. The cellular machinery that copies DNA occasionally inserts the wrong letter, skips a section, or duplicates one. Repair systems catch most of these errors, but the repair process itself can introduce small changes.
At a larger scale, entire chromosomes can be gained or lost when they fail to separate properly during cell division. Chunks of chromosomes can swap places, get deleted, or get duplicated through a process called non-allelic homologous recombination. Nearly every type of genetic variation has been documented as a source of somatic (body cell) mosaicism, including single-letter misspellings, gains or losses of chromosome segments, and even “jumping genes” that copy themselves into new locations in the genome.
The timing of the error matters enormously. A mutation that occurs in one of the first few cell divisions after conception will be present in a large fraction of the body’s cells, potentially affecting multiple organs. A mutation that occurs later, in a tissue that’s already partially formed, will be confined to a small patch of cells. This is why mosaic conditions range from barely detectable to severe.
Mosaic Conditions in the Body
Several well-known medical conditions exist only as mosaics, meaning the genetic change would be fatal if it were present in every cell.
McCune-Albright syndrome is one classic example. First described in 1936, it involves a triad of café-au-lait skin spots, early puberty, and fibrous dysplasia (where bone is replaced by fibrous tissue). The cause is a specific mutation on chromosome 20 that locks a growth-signaling protein into an “always on” state. Because the mutation is lethal if present throughout the body, every person with McCune-Albright syndrome is a mosaic: only some of their cells carry the change.
Proteus syndrome follows a similar pattern. A single-letter misspelling in the AKT1 gene acts like a stuck accelerator for cell growth, but only in the tissues that carry the mutation. This leads to dramatic, asymmetric overgrowth of limbs, skin thickening, and sometimes neurological complications like seizures or vision loss. Researchers at the National Human Genome Research Institute identified this mutation in 2011, confirming that the condition is fundamentally mosaic.
Mosaicism in the Brain
The brain is particularly susceptible to the effects of mosaicism because neurons, once formed, generally don’t get replaced. A mutation that occurs during brain development can create a patch of abnormal tissue that persists for life.
Focal cortical dysplasia, a common cause of drug-resistant epilepsy, results from mosaic mutations in genes that control cell growth and brain organization. The mutations affect only a localized region of the brain’s outer layer, creating a malformed patch that generates seizures. A more extreme version, hemimegalencephaly, involves one entire hemisphere of the brain growing abnormally large. Both conditions have been linked to mosaic mutations in growth-pathway genes, including some of the same pathways disrupted in Proteus syndrome.
Mosaicism, Aging, and Cancer
Mosaicism isn’t just something you’re born with. It accumulates throughout life as cells continue dividing and accumulating errors. By age 60, an estimated 15 to 20 percent of people have detectable clonal hematopoiesis of indeterminate potential, a condition where a mutated blood stem cell has produced a measurable population of genetically identical descendants. The mutated clone hasn’t caused disease yet, but its presence is associated with a higher risk of blood cancers and cardiovascular disease.
The connection between mosaicism and cancer is intuitive: cancer begins when a cell acquires enough mutations to grow without restraint. What’s less obvious is that normal tissues already carry a surprising burden of mutations. A sequencing study of normal skin found a heavy load of UV-related mutations in skin biopsies from people without cancer, closely matching the mutational signature caused by sun exposure. This suggests that patches of mutated-but-not-yet-cancerous cells are a normal feature of sun-exposed skin, and that the boundary between “mosaic tissue” and “precancerous tissue” can be blurry.
Researchers have also proposed that mosaic changes in immune cells could affect the body’s ability to detect and destroy precancerous cells elsewhere. If immune cells carrying certain mutations become less effective at recognizing abnormal growths, mosaicism in the blood could indirectly raise the risk of solid tumors in other organs.
Detecting Low-Level Mosaicism
Traditional DNA sequencing (Sanger sequencing) reads the average genetic signal from a sample of cells. If only a small fraction of cells carry a mutation, the signal gets drowned out by the normal majority. This means Sanger sequencing reliably misses low-level mosaicism.
Next-generation sequencing has changed this by reading DNA from individual fragments at very high depth, making it possible to spot a mutated version even when it represents a small minority of cells. Targeted next-generation sequencing can detect mutations present in as few as 2 percent of the cells in a sample. In one striking case, deep sequencing of a mother who was a mosaic carrier for a muscle disease gene found the mutation at levels of just 0.4 percent in saliva, 1.1 percent in blood, and 8.3 percent in nail tissue. The variation across tissues highlights that mosaicism is not uniform throughout the body, and testing a single tissue can miss it entirely.
Implications for Families
Mosaicism creates a particular challenge for genetic counseling. When a child is born with a condition caused by an apparently new (de novo) mutation, the assumption is often that both parents have zero risk of having another affected child. But if one parent carries the mutation in a fraction of their egg or sperm cells, a situation called germline mosaicism, the recurrence risk is real.
For Duchenne and Becker muscular dystrophy, studies estimate that mothers of a child with a confirmed de novo mutation face a recurrence risk of roughly 4 to 11 percent for a future male pregnancy, with an average around 6 percent. This is far higher than the near-zero risk that would be expected if the mutation were truly a one-time event. The same principle applies across many genetic conditions: a negative blood test in a parent doesn’t rule out mosaicism in reproductive cells, because germline tissue and blood are separate lineages that diverged early in development.
For families navigating these decisions, the key takeaway is that “de novo” doesn’t always mean “won’t happen again.” Prenatal testing in subsequent pregnancies can provide more definitive answers when germline mosaicism is suspected.